Answer
Yes, Zypadhera is contraindicated in patients with a known risk of narrow-angle glaucoma.
Sources for this answer
- ZYPADHERA 210 mg, 300 mg and 405 mg powder and solvent for prolonged release suspension for injectionNeon Healthcare Ltd · emc · SmPC §4.3 Contraindications · Version 2Document updated
Sources checked